Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
The recap is part of the lengthy restructuring of scandal hit company -
The French IT services company is seeking to avoid a damaging debt for equity swap through asset sales and refinancing talks
-
The capital increase secured a 69% take-up from investors
-
Existing shareholders each gave away part of or all of their rights, making way for new family office to wield a stake
-
The Fed's dovish talk of rate cuts next year has boosted stocks, and the IPO pipeline is slowly building
-
The Swedish landlord's rights issue attracted strong support
